(Total Views: 557)
Posted On: 01/11/2022 4:12:40 PM
Post# of 148899
Re: Cassandra X #114733
This is not the first time the Vyera contract has been moved to another entity.
Per the 10q, it was transferred from Vyera to Sevenscore Pharmaceuticals, another subsidiary of Vyera's parent company Phoenixus, in Oct 2020. Then it was transferred from Sevenscore to Regnum last month. The 10q filed yesterday was the first time we've been made aware of the Oct 2020 transfer.
I guess Cytodyn brass felt like it was a mundane internal rearrangement by Phoenixus so they didn't feel the need to include it in filings until the Regnum transfer was filed with the SEC by Regnum and became a point of internet discussion over the last few days. I definitely would have liked to have been told about it when it happened back in 2020 but it's a minor point in that it probably makes no material difference with the Vyera contract.
Per the 10q, it was transferred from Vyera to Sevenscore Pharmaceuticals, another subsidiary of Vyera's parent company Phoenixus, in Oct 2020. Then it was transferred from Sevenscore to Regnum last month. The 10q filed yesterday was the first time we've been made aware of the Oct 2020 transfer.
I guess Cytodyn brass felt like it was a mundane internal rearrangement by Phoenixus so they didn't feel the need to include it in filings until the Regnum transfer was filed with the SEC by Regnum and became a point of internet discussion over the last few days. I definitely would have liked to have been told about it when it happened back in 2020 but it's a minor point in that it probably makes no material difference with the Vyera contract.
(1)
(0)Scroll down for more posts ▼
